SALT LAKE CITY, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company has filed a U.S. provisional patent application entitled, “Kinetically Controlled Method of In Situ Generation of Nitric Oxide in an Aqueous Solution.” The patent broadly covers the kinetically controlled generation of nitric oxide in an aqueous solution to provide a time dose curve that can be effectively used for treatment of various dermal wounds.

Go here to read the rest:
Nu-Med Plus Announces Filing of U.S. Provisional Patent Application for Nitric Oxide in Aqueous Solution for Wound Care Treatment